Subscribe to RSS
DOI: 10.1055/s-0044-1782227
Natural History and Endoscopic Management of Pancreaticopleural Fistula: A Tertiary Care Center Experience
Funding The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. The authors have no relevant financial or non-financial interests to disclose. This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University (Sanjay Gandhi Post-Graduate Institute of Medical Sciences Lucknow) The study was approved by the institutional committee and was conducted in accordance with the Declaration of Helsinki.Abstract
Background Pancreaticopleural fistula (PPF) is a rare complication associated with pancreatitis, caused by disruption of the pancreatic duct, either directly or through rupture of a peripancreatic fluid collection, resulting in leakage of pancreatic juice into the pleural space. It commonly presents as massive, relapsing pleural effusions, often on the left side with high amylase content. Nonspecific chest symptoms often predominate, making it a diagnostic challenge. There is a lack of clarity regarding the management of this rare entity.
Objectives This study aimed to review the typical presentations, pathophysiology, and current role of endoscopic therapy in patients with PPF.
Materials and Methods A retrospective analysis of the results of endoscopic treatment of patients with symptomatic PPF due to pancreatitis was done.
Results Ten patients with pancreatitis (6 males; mean age 33.6 ± 15.4 years: 6 chronic, 4 acute) with symptomatic PPF were analyzed. Endoscopic retrograde cholangiopancreatography was performed in all, with pancreatic sphincterotomy and stenting of the main pancreatic duct (passive transpapillary drainage). Technical and clinical success was achieved in 7/10(70%) and 10/10(100%) patients, respectively. Though the leak was bridged in three patients, pancreatic sphincterotomy and downstream stenting (when bridging was not possible) were successful in closing PPF. One (10%) patient needed surgery for gastric outlet obstruction. The mean duration of endotherapy was 12.1 ± 9.4 months and the time taken for leak closure was 15.3 ± 10.4 weeks. Long-term success of endoscopic treatment (median follow-up period of 48.9 ± 28.7 months) was achieved in all patients.
Conclusions Endoscopic treatment (passive trans-papillary drainage) is a safe and effective procedure for managing postinflammatory PPFs, and should be attempted in cases of failure of medical treatment.
Keywords
pancreaticopleural fistula - pancreatitis - pleural effusion - endoscopic retrograde cholangiopancreatographyAuthors' Contributions
S.M. and V.A.S were involved in conceptualization, methodology, investigation, validation, resources, writing (original draft, review and editing), visualization, and supervision. P.D. and S.R.K. contributed to methodology, validation, writing (review and editing), and visualization. S.M. helped in methodology, investigation, data collection, validation, resources, and writing (original draft, review, and editing). D.T. and N.K. contributed to resources, visualization, and writing (reviewing and editing). K.B. helped in format analysis, reviewing, and editing. G.P. contributed to resources, visualization, and supervision.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Publication History
Article published online:
27 March 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Chebli JMF, Gaburri PD, de Souza AF. et al. Internal pancreatic fistulas: proposal of a management algorithm based on a case series analysis. J Clin Gastroenterol 2004; 38 (09) 795-800
- 2 Chang LH, Francoeur L, Schweiger F. Pancreaticoportal fistula in association with antiphospholipid syndrome presenting as ascites and portal system thrombosis. Can J Gastroenterol 2002; 16 (09) 601-605
- 3 Miller JA, Maldjian P, Seeff J. Pancreaticopleural fistula. An unusual cause of persistent unilateral pleural effusion. Clin Imaging 1998; 22 (02) 105-107
- 4 Uchiyama T, Suzuki T, Adachi A, Hiraki S, Iizuka N. Pancreatic pleural effusion: case report and review of 113 cases in Japan. Am J Gastroenterol 1992; 87 (03) 387-391
- 5 Pai CG, Suvarna D, Bhat G. Endoscopic treatment as first-line therapy for pancreatic ascites and pleural effusion. J Gastroenterol Hepatol 2009; 24 (07) 1198-1202
- 6 Gupta S, Gaikwad N, Samarth A, Sawalakhe N, Sankalecha T. Efficacy of pancreatic endotherapy in pancreatic ascites and pleural effusion. Med Sci (Basel) 2017; 5 (02) 6
- 7 Hastier P, Rouquier P, Buckley M, Simler JM, Dumas R, Delmont JP. Endoscopic treatment of wirsungo-cysto-pleural fistula. Eur J Gastroenterol Hepatol 1998; 10 (06) 527-529
- 8 Kutz Leoz M, Irisarri Garde R, Vila Costas JJ, Martínez Echeverría A, Elizalde Apestegui I, Basterra Ederra M, Gómez Alonso M, Zozaya Urmeneta JM. [Pleural effusion secondary to pancreaticopleural fistula following acute pancreatitis]. Gastroenterol Hepatol 2012; Feb; 35 (02) 70-73 . Spanish. doi: 10.1016/j.gastrohep.2011.10.008. Epub 2012 Jan 11. PMID: 22240268
- 9 Kozarek RA, Ball TJ, Patterson DJ, Freeny PC, Ryan JA, Traverso LW. Endoscopic transpapillary therapy for disrupted pancreatic duct and peripancreatic fluid collections. Gastroenterology 1991; 100 (5 Pt 1): 1362-1370
- 10 Larsen M, Kozarek R. Management of pancreatic ductal leaks and fistulae. J Gastroenterol Hepatol 2014; 29 (07) 1360-1370
- 11 Bhasin DK, Rana SS, Siyad I. et al. Endoscopic transpapillary nasopancreatic drainage alone to treat pancreatic ascites and pleural effusion. J Gastroenterol Hepatol 2006; 21 (06) 1059-1064
- 12 Varadarajulu S, Noone TC, Tutuian R, Hawes RH, Cotton PB. Predictors of outcome in pancreatic duct disruption managed by endoscopic transpapillary stent placement. Gastrointest Endosc 2005; 61 (04) 568-575
- 13 Kim S, Kim JW, Jung PY. et al. Diagnostic and therapeutic role of endoscopic retrograde pancreatography in the management of traumatic pancreatic duct injury patients: single center experience for 34 years. Int J Surg 2017; 42: 152-157
- 14 Dhebri AR, Ferran N. Nonsurgical management of pancreaticopleural fistula. JOP 2005; 6 (02) 152-161
- 15 Ferris H, Buckley M. Pancreaticopleural fistula: an unusual complication of chronic pancreatitis. Ir Med J 2012; 105 (07) 246-247
- 16 Gestic MA, Callejas-Neto F, Chaim EA. et al Tratamento cirúrgico da pancreatite crônica com a técnica de F rey: panorama atual. ABCD, [Surgical treatment of chronic pancreatitis with frey procedure: current situation] arq bras cir dig 2011; 24 (04) 305-311
- 17 Meybeck A, Gouteux D, Bolard F, Salez F, Guillemot P, Barbieux H. [A rare complication of chronic pancreatitis: pancreatico-pleural fistula]. Rev Pneumol Clin 2003; 59 (04) 205-208
- 18 Neumann S, Caca K, Mössner J. Pankreatikopleurale Fistel bei chronischer Pankreatitis mit Pankreasschwanznekrose [Pancreatico-pleural fistula in chronic pancreatitis with necrosis of the pancreatic tail]. Dtsch Med Wochenschr 2004; Aug 20; 129 (34–35): 1802-1805 . German. doi: 10.1055/s-2004-829032. PMID: 15314743
- 19 Rushforth JA, Beck JM, McMahon M, Puntis JW. Resolution of pancreatic ascites with octreotide. Arch Dis Child 1993; 68 (01) 135-136
- 20 Kurumboor P, Varma D, Rajan M. et al. Outcome of pancreatic ascites in patients with tropical calcific pancreatitis managed using a uniform treatment protocol. Indian J Gastroenterol 2009; 28 (03) 102-106
- 21 Bhasin DK, Dhavan S, Sriram PV. et al. Endoscopic management of pancreatic diseases. Indian J Gastroenterol 1997; 16 (04) 151-152
- 22 Agarwal J, Nageshwar Reddy D, Talukdar R. et al. ERCP in the management of pancreatic diseases in children. Gastrointest Endosc 2014; 79 (02) 271-278
- 23 Felux J, Sturm E, Busch A. et al. Sa1178 ERCP in infants, children and adolescents is feasible and safe – results from a tertiary care center. Gastrointest Endosc 2016; 83 (05) AB243-AB244
- 24 Zubiaurre L, Oyarzabal I, Beguiristain A, Amato E, Zapata E, Salvador P. Fístula pancreaticopleural: pruebas diagnósticas y tratamiento [Pancreaticopleural fistula: diagnostic tests and treatment]. Cir Esp 2005; Jun; 77 (06) 359-361 . Spanish. doi: 10.1016/s0009-739x(05)70871-x. PMID: 16420951
- 25 Parekh D, Segal I. Pancreatic ascites and effusion. Risk factors for failure of conservative therapy and the role of octreotide. Arch Surg 1992; 127 (06) 707-712
- 26 Jagielski M, Piątkowski J, Jackowski M. Endoscopic treatment of pancreaticopleural fistulas. Front Cell Infect Microbiol 2022; 12: 939137
- 27 Ali T, Srinivasan N, Le V, Chimpiri AR, Tierney WM. Pancreaticopleural fistula. Pancreas 2009; 38 (01) e26-e31